CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project seeks to optimize the treatment of ventilator-associated pneumonia caused by multidrug-resistant bacteria. By comparing colistin and meropenem in a clinical trial, the project aims to establish effective empirical therapies and reduce the time needed for pathogen identification.
Background.
Ventilator-associated pneumonia (VAP) is one of the most common and severe hospital-adquired infections, and multidrugresistant gram-negative bacilli (MDR-GNB) constitute the main etiology in many countries.
Inappropriate empiric antimicrobial treatment is associated with increased mortality.
In this context, the empirical treatment of choice for VAP is unknown.
Colistin, and “old” drug, is now the antimicrobial with greatest in vitro activity against MDR-GNB.
However, no randomized…
SERVICIO ANDALUZ DE SALUD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, ORSAY CEDEX
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
KLINIKUM DER UNIVERSITAET ZU KOELN
Germany, Koeln
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Milano
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Greece, Athina
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
